Study of Letrozole in Recurrent Gliomas

• Status: Recruiting
• Trial end date: 2023-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the ability of letrozole to penetrate the blood brain barrier and concentrate in gliomas.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Cincinnati
• Treatments: Letrozole

Criteria

Inclusion Criteria:

• Recurrent brain glioma with plan for resection or biopsy.

• ECOG 0-2

• Adequate labs

Exclusion Criteria:

• Receiving other investigational agents.